Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Journal of Gastroenterology and Hepatology|December 22, 2017
Predicting response after infliximab salvage in acute severe ulcerative colitisMatthew C Choy, Dean Seah, Alexandra Gorelik, et al.European Journal of Gastroenterology & Hepatology|May 5, 2018
Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel diseaseWebber Chan, Nicole Lynch, Peter Bampton, et al.JCI Insight|February 9, 2018
Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunctionMichael Fricker, Bridie J Goggins, Sean Mateer, et al.Inflammatory Bowel Diseases|January 4, 2019
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative ColitisMatthew C Choy, Dean Seah, David M Faleck, et al.Journal of Gastroenterology and Hepatology|July 28, 2025
Point-of-Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional InvestigationsWei-Lian Tan, Emi Khoo, Myat-Myat Khaing, et al.The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trialsDavid T Rubin, Iris Dotan, Aaron DuVall, et al.Journal of Crohn'S & Colitis|December 2, 2025
Cost-effective inflammatory bowel disease flare pathway with nurse-led triage and rapid access intestinal ultrasound reduces hospital resource use with high patient satisfactionRichard G Fernandes, Emi Khoo, Heidi Jensen Harris, et al.Clinical and Translational Gastroenterology|January 29, 2021
Randomized, Placebo Controlled Trial of Experimental Hookworm Infection for Improving Gluten Tolerance in Celiac DiseaseJohn Croese, Gregory C Miller, Louise Marquart, et al.BMJ Open|July 2, 2021
Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocolBonita Gu, Michael De Gregorio, Joseph Louis Pipicella, et al.Journal of Gastroenterology and Hepatology|February 28, 2025
Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for ConcernPaulina Suo, Ashish Srinivasan, Lena Thin, et al.Pageof 7